Heron Therapeutics, Inc. · NASDAQ:HRTX

Hensley Mark Earl exercised options for 11,769 Heron Therapeutics, Inc. shares (Form 4)

Traded Jul 31, 2026 · Filed Aug 3, 2026

On Jul 31, 2026, Hensley Mark Earl (Chief Operating Officer) exercised options for 11,769 Heron Therapeutics, Inc. shares, leaving 148,539 shares. Filed Aug 3, 2026 (Form 4).

Options exercised
11,769 shares
Holding after
148,539 shares
Trading plan
No
Role
Chief Operating Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 31, 2026Common StockOption exercise11,769148,539Direct

Source

View original at SEC

Related